Average Co-Inventor Count = 3.04
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (8 from 666 patents)
2. Incyte Holdings Corporation (4 from 147 patents)
3. Bristol-myers Squibb Pharma Company (3 from 234 patents)
4. Bristol-myers Squibb Compnay (2 from 3,685 patents)
5. Astrazeneca Ab (2 from 1,500 patents)
6. Other (1 from 832,880 patents)
16 patents:
1. 12024522 - Salts and processes of preparing a PI3K inhibitor
2. 11787784 - Solid forms of an HPK1 inhibitor
3. 11066394 - Solid forms of an HPK1 inhibitor
4. 10858372 - Amorphous solid form of a BET protein inhibitor
5. 10329305 - Amorphous solid form of a BET protein inhibitor
6. 10280157 - Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
7. 9873688 - Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
8. 9321755 - Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
9. 9035065 - Ethanamine compounds and methods of using the same
10. 8013165 - Ethanamine compounds and methods of using the same 545
11. 6589958 - Isoxazolo [4,5-d] pyrimidines as CRF antagonists
12. 6579876 - Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
13. 6521636 - Imidazo-pyridines as corticotropin releasing factor antagonists
14. 6509338 - Pyrazolo[1,5-A]triazine corticotropin releasing factor antagonists
15. 6365589 - Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists